Peptide Push Amid Safety Gaps | Tucson News

Peptide compounds are sparking a heated debate as a federal advisory panel narrowly votes to make six of them more accessible—despite a lack of human safety data. Once restricted by the FDA in 2023 over safety and effectiveness concerns, these substances are now being touted online for weight loss, injury recovery, and immunity boosts, flooding clinics and clinics nationwide. While some patients report dramatic results, medical professionals remain skeptical. The final decision still rests with the FDA and HHS, leaving the future of these compounds uncertain amid rising public demand and mounting scientific scrutiny. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/fadddc1627ce450d